(Q37698206)

22 August 2017

1 reference

title

The role of platelet-activating factor in asthma (English)

1 reference

22 August 2017

0 references

Smith LJ

1

1 reference

22 August 2017

language of work or name

1 reference

1 May 1991

1 reference

The American Review of Respiratory Disease

22 August 2017

published in

1 reference

22 August 2017

volume

143

1 reference

22 August 2017

issue

5 Pt 2

1 reference

22 August 2017

page(s)

S100-2

1 reference

New concepts in the pathogenesis of bronchial hyperresponsiveness and asthma

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F143.5_PT_2.S100

Role of inflammation in the hyperreactivity of the airways in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F143.5_PT_2.S100

Effects of Inhaled PAF in Humans on Circulating and Bronchoalveolar Lavage Fluid Neutrophils: Relationship to Bronchoconstriction and Changes in Airway Responsiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F143.5_PT_2.S100

Platelet-activating factor. A potent chemotactic and chemokinetic factor for human eosinophils.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F143.5_PT_2.S100

Platelet-activating factor raises airway and vascular pressures and induces edema in lungs perfused with platelet-free solution

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F143.5_PT_2.S100

Effects of platelet activating factor on airway calibre, airway responsiveness, and circulating cells in asthmatic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F143.5_PT_2.S100

Ketotifen inhibits the cutaneous but not the airway responses to platelet-activating factor in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F143.5_PT_2.S100

10.1164/AJRCCM/143.5_PT_2.S100

21 January 2018

Identifiers

DOI

0 references

1 reference